Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-04

Clinical Trial Update: Efficacy and Safety of Immunoglobulin Associated With Rituximab Versus Rituximab Alone in Childhood-Onset Steroid-dependent Nephrotic Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent nephrotic syndrome; trial status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Immunoglobulin (immunoglobulin)
  • Rituximab (rituximab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Steroid-Dependent Nephrotic Syndrome | Phase 2, Phase 3 | Status: SUSPENDED